• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在数字医学中推进多样性、公平性和包容性所面临的社会伦理挑战与机遇。

Socio-ethical challenges and opportunities for advancing diversity, equity, and inclusion in digital medicine.

作者信息

Paccoud Ivana, Leist Anja K, Schwaninger Isabel, van Kessel Robin, Klucken Jochen

机构信息

Digital Medicine Group, Department of Population Health, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.

Digital Medicine, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.

出版信息

Digit Health. 2024 Oct 1;10:20552076241277705. doi: 10.1177/20552076241277705. eCollection 2024 Jan-Dec.

DOI:10.1177/20552076241277705
PMID:39372817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11450794/
Abstract

Digitalization in medicine offers a significant opportunity to transform healthcare systems by providing novel digital tools and services to guide personalized prevention, prediction, diagnosis, treatment and disease management. This transformation raises a number of novel socio-ethical considerations for individuals and society as a whole, which need to be appropriately addressed to ensure that digital medical devices (DMDs) are widely adopted and benefit all patients as well as healthcare service providers. In this narrative review, based on a broad literature search in PubMed, Web of Science, Google Scholar, we outline five core socio-ethical considerations in digital medicine that intersect with the notions of equity and digital inclusion: (i) access, use and engagement with DMDs, (ii) inclusiveness in DMD clinical trials, (iii) algorithm fairness, (iv) surveillance and datafication, and (v) data privacy and trust. By integrating literature from multidisciplinary fields, including social, medical, and computer sciences, we shed light on challenges and opportunities related to the development and adoption of DMDs. We begin with an overview of the different types of DMDs, followed by in-depth discussions of five socio-ethical implications associated with their deployment. Concluding our review, we provide evidence-based multilevel recommendations aimed at fostering a more inclusive digital landscape to ensure that the development and integration of DMDs in healthcare mitigate rather than cause, maintain or exacerbate health inequities.

摘要

医学数字化提供了一个重大机遇,通过提供新颖的数字工具和服务来指导个性化预防、预测、诊断、治疗和疾病管理,从而改变医疗保健系统。这种转变给个人乃至整个社会带来了一些新的社会伦理考量,需要加以妥善解决,以确保数字医疗设备(DMD)得到广泛应用,并使所有患者以及医疗服务提供者受益。在这篇叙述性综述中,基于在PubMed、科学网、谷歌学术上进行的广泛文献检索,我们概述了数字医学中与公平和数字包容概念相关的五个核心社会伦理考量:(i)DMD的获取、使用和参与度;(ii)DMD临床试验的包容性;(iii)算法公平性;(iv)监测与数据化;(v)数据隐私与信任。通过整合来自社会、医学和计算机科学等多学科领域的文献,我们阐明了与DMD开发和应用相关的挑战与机遇。我们首先概述不同类型的DMD,随后深入讨论与其部署相关的五个社会伦理影响。在综述结尾,我们提供基于证据的多层次建议,旨在营造一个更具包容性的数字环境,以确保DMD在医疗保健中的开发和整合能够减少而非导致、维持或加剧健康不平等现象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7455/11450794/b0296f97e475/10.1177_20552076241277705-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7455/11450794/7bc53dc4cdd9/10.1177_20552076241277705-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7455/11450794/b0296f97e475/10.1177_20552076241277705-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7455/11450794/7bc53dc4cdd9/10.1177_20552076241277705-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7455/11450794/b0296f97e475/10.1177_20552076241277705-fig2.jpg

相似文献

1
Socio-ethical challenges and opportunities for advancing diversity, equity, and inclusion in digital medicine.在数字医学中推进多样性、公平性和包容性所面临的社会伦理挑战与机遇。
Digit Health. 2024 Oct 1;10:20552076241277705. doi: 10.1177/20552076241277705. eCollection 2024 Jan-Dec.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Advancing digital health equity: Directions for behavioral and social science research.推进数字健康公平:行为与社会科学研究方向。
Transl Behav Med. 2023 Apr 3;13(3):132-139. doi: 10.1093/tbm/ibac088.
4
Fairness of artificial intelligence in healthcare: review and recommendations.人工智能在医疗保健中的公平性:综述与建议。
Jpn J Radiol. 2024 Jan;42(1):3-15. doi: 10.1007/s11604-023-01474-3. Epub 2023 Aug 4.
5
Digital Health Equity: Addressing Power, Usability, and Trust to Strengthen Health Systems.数字健康公平:解决权力、可用性和信任问题,以加强卫生系统。
Yearb Med Inform. 2022 Aug;31(1):20-32. doi: 10.1055/s-0042-1742512. Epub 2022 Dec 4.
6
Ethical considerations for artificial intelligence in dermatology: a scoping review.人工智能在皮肤科应用的伦理考量:范围综述。
Br J Dermatol. 2024 May 17;190(6):789-797. doi: 10.1093/bjd/ljae040.
7
Ethical, legal, and social implications of digital health: A needs assessment from the Society of Behavioral Medicine to inform capacity building for behavioral scientists.数字健康的伦理、法律和社会影响:来自行为医学学会的需求评估,以告知行为科学家的能力建设。
Transl Behav Med. 2024 Feb 23;14(3):189-196. doi: 10.1093/tbm/ibad076.
8
Artificial Intelligence, the Digital Surgeon: Unravelling Its Emerging Footprint in Healthcare - The Narrative Review.人工智能,数字外科医生:揭示其在医疗保健领域的新兴足迹——叙述性综述
J Multidiscip Healthc. 2024 Aug 15;17:4011-4022. doi: 10.2147/JMDH.S482757. eCollection 2024.
9
Recommendations for ethical and responsible use of artificial intelligence in digital agriculture.数字农业中人工智能的道德与负责任使用建议。
Front Artif Intell. 2022 Jul 29;5:884192. doi: 10.3389/frai.2022.884192. eCollection 2022.
10
Exploring the Role of Artificial Intelligence in Mental Healthcare: Current Trends and Future Directions - A Narrative Review for a Comprehensive Insight.探索人工智能在精神卫生保健中的作用:当前趋势与未来方向——全面洞察的叙述性综述
Risk Manag Healthc Policy. 2024 May 21;17:1339-1348. doi: 10.2147/RMHP.S461562. eCollection 2024.

引用本文的文献

1
Data-driven FMEA approach for hazard identification and risk evaluation in digital health.用于数字健康中危害识别与风险评估的数据驱动型失效模式与效应分析方法
Sci Rep. 2025 Jul 23;15(1):26856. doi: 10.1038/s41598-025-11929-4.
2
Engagement and attrition in digital mental health: current challenges and potential solutions.数字心理健康中的参与度与损耗率:当前挑战与潜在解决方案
NPJ Digit Med. 2025 Jul 2;8(1):398. doi: 10.1038/s41746-025-01778-w.
3
Empowering Capabilities of People With Chronic Conditions Supported by Digital Health Technologies: Scoping Review.

本文引用的文献

1
Advancing equity in medical device performance.提高医疗设备性能的公平性。
Lancet Glob Health. 2024 May;12(5):e712. doi: 10.1016/S2214-109X(24)00141-4.
2
Ethical, legal, and social implications (ELSI) of virtual agents and virtual reality in healthcare.医疗保健中虚拟代理和虚拟现实的伦理、法律和社会影响(ELSI)。
Soc Sci Med. 2024 Jan;340:116483. doi: 10.1016/j.socscimed.2023.116483. Epub 2023 Dec 1.
3
Federated electronic health records for the European Health Data Space.用于欧洲健康数据空间的联邦电子健康记录。
数字健康技术支持下慢性病患者的能力赋能:范围综述
J Med Internet Res. 2025 Jun 27;27:e68458. doi: 10.2196/68458.
4
Insights into the Technological Evolution and Research Trends of Mobile Health: Bibliometric Analysis.移动健康的技术演变与研究趋势洞察:文献计量分析
Healthcare (Basel). 2025 Mar 26;13(7):740. doi: 10.3390/healthcare13070740.
5
A scoping review and expert consensus on digital determinants of health.关于健康数字决定因素的范围综述与专家共识
Bull World Health Organ. 2025 Feb 1;103(2):110-125H. doi: 10.2471/BLT.24.292057. Epub 2024 Oct 29.
6
Patient perspectives on the use of digital medical devices and health data for AI-driven personalised medicine in Parkinson's Disease.帕金森病患者对使用数字医疗设备和健康数据进行人工智能驱动的个性化医疗的看法。
Front Neurol. 2024 Dec 4;15:1453243. doi: 10.3389/fneur.2024.1453243. eCollection 2024.
Lancet Digit Health. 2023 Nov;5(11):e840-e847. doi: 10.1016/S2589-7500(23)00156-5. Epub 2023 Sep 21.
4
FAIR for AI: An interdisciplinary and international community building perspective.公平对待人工智能:跨学科和国际化的社区建设视角。
Sci Data. 2023 Jul 26;10(1):487. doi: 10.1038/s41597-023-02298-6.
5
Mapping Factors That Affect the Uptake of Digital Therapeutics Within Health Systems: Scoping Review.映射影响数字疗法在医疗体系内采用的因素:范围综述。
J Med Internet Res. 2023 Jul 25;25:e48000. doi: 10.2196/48000.
6
The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review.COVID-19 期间物质使用障碍的远程精神病学发展:一项叙述性综述
Curr Addict Rep. 2023;10(2):187-197. doi: 10.1007/s40429-023-00480-9. Epub 2023 Apr 25.
7
Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes.加利福尼亚州在 COVID-19 政策变化后,按年龄、种族、族裔和社会经济地位划分的总体和远程医疗成瘾治疗利用率。
JAMA Health Forum. 2023 May 5;4(5):e231018. doi: 10.1001/jamahealthforum.2023.1018.
8
Is Europe prepared to go digital? making the case for developing digital capacity: An exploratory analysis of Eurostat survey data.欧洲准备好迈向数字化了吗?论证发展数字能力的必要性:对欧盟统计局调查数据的探索性分析
PLOS Digit Health. 2022 Feb 17;1(2):e0000013. doi: 10.1371/journal.pdig.0000013. eCollection 2022 Feb.
9
Advancing digital health equity: Directions for behavioral and social science research.推进数字健康公平:行为与社会科学研究方向。
Transl Behav Med. 2023 Apr 3;13(3):132-139. doi: 10.1093/tbm/ibac088.
10
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project.估算美国痴呆症和轻度认知障碍的患病率:2016 年健康退休研究协调认知评估方案项目。
JAMA Neurol. 2022 Dec 1;79(12):1242-1249. doi: 10.1001/jamaneurol.2022.3543.